Translation. Region: Russian Federation –
Source: Novosibirsk State University –
An important disclaimer is at the bottom of this article.
Council for Support of Development Programs of Universities Participating in the ProgramPriority 2030 summarized the results of its work. Over the course of four days from November 18 to 21, the Ministry of Higher Education and Science, along with experts from the business and scientific communities, reviewed the universities' preliminary results.
NSU has entered the second group of the main track and will receive support in the amount of approximately 400 million rubles for the implementation of the development program in 2026. Yesterday, a press conference was held at TASS with the participation of Andrey Matveyev, Head of the NSU Development Program Coordination Department, and the Deputy Director Institute of Medicine and Medical Technologies of NSU Mikhail Khvostov, Professor of Biomedical Research and Pharmaceutics, presented the key results and research areas that NSU will develop as part of the Priority 2030 program in 2026.
"As part of the development program, which we practically re-formulated at the beginning of this year, we set ourselves the goal of developing NSU as a scientific and technological university. This target model will be implemented through strategic technology projects," Andrey Matveyev noted at the beginning of his speech.
The Center for the Integration of Personalized Biomedicine, Pharmacy, and Synchrotron and Binary Technologies, which was launched this year, became a strategic nuclear technology project (STP) for NSU.
"In a relatively short period of time, we've managed to assemble a fairly large team—over 100 scientists working on interdisciplinary projects. These people possess expertise in various fields, and this helps us implement important, interesting, and breakthrough ideas. We have a very ambitious goal—to develop at least 50 domestic biomedical products by 2030," said Mikhail Khvostov.
Achieving this goal will be facilitated by consolidating the university's activities with research institutes of the Siberian Branch of the Russian Academy of Sciences and industrial partners, as well as NSU's undeniable advantage—fundamental education of the highest level, including in the field of biomedicine.
"Another key development is the construction of a new NSU campus and the development of new infrastructure. This is a research center that will house, among other things, a pilot industrial production facility for biotech products. This infrastructure will accelerate the transfer of new ideas, technologies, and developments generated at NSU and the SB RAS research institutes to the real economy. For biomedical products, this is a long and arduous process; however, the university is now prepared to implement the full life cycle of such products—from conception and prototyping to the transfer of technologies and medical devices to the real economy," added Mikhail Khvostov.
STP's portfolio currently includes over 15 products at various stages of development, representing various segments and primarily related to personalized medicine. All products are being developed with the support of industrial partners, who are ready to bring them to market.
Thus, the development of NGS sequencing platforms potentially enables more accurate diagnosis of various diseases and the prescription of appropriate treatment. Another area of research is related to the SKIF Center for Collective Use, which will enable the full cycle of pre- and post-synchrotron research, which is necessary, for example, for studying potential drugs, their mechanisms of action, and for analyzing pharmaceutical substances.
The most advanced product development is for lower and upper limb prosthetics created using additive manufacturing. Prototypes are currently being tested with patients, and it is planned that this development will be ready for industrial deployment by 2026.
NSU is also currently a site for the development of reagents for the CAR-T therapy ecosystem—one of the modern methods for treating oncohematological diseases.
Another strategic technology project being developed by NSU as part of the Priority 2030 program is "Neural Network Technologies for Processing Targeted Information onboard Small Spacecraft and Controlling Unmanned Aerial Vehicles." It comprises two subprojects. One is related to the development of neural modules that will be installed on satellites. These modules will reduce energy consumption and improve satellite efficiency by pre-processing the information received onboard.
"For example, some of the images received by Earth remote sensing satellites contain cloud cover, which complicates their processing. There's no point in transmitting such images beyond Earth. Neural modules will pre-process the information received by the satellite and transmit only the relevant information to Earth," explained Andrey Matveyev.
The second subproject involves the development of unmanned aerial vehicles with autonomous ground navigation systems, where the drone navigates by analyzing its surroundings and independently performs its assigned task. Such devices have everyday applications, for example, for delivering medicine and essential goods to hard-to-reach areas. Ten such aircraft have already been manufactured for partners.
The third STP—"Artificial Intelligence for Production Facilities and Automation of Industry and the Urban Environment"—includes a range of products and technologies for the efficient management of urban infrastructures and industrial enterprises, automation of production, and improvement of quality of life. Work on the project is being carried out with the support of both large federal and regional companies.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.